Company: G
Filing Date: 2025-11-07
Form Type: 10-Q
Source: 0001398659-25-000109
Chunk: 162

Company: Genpact LTD
Filing Date: 2025-11-07
Form: 10-Q
Item: Part I, Item 8
Chunk 162
---
oss) recognized in OCI on Derivatives (Effective Portion)Location of Gain (Loss) reclassified from OCI into Statement of Income (Effective Portion)Amount of Gain (Loss) reclassified from OCI into Statement of Income (Effective Portion)Three months ended September 30,Nine months ended September 30,Three months ended September 30,Nine months ended September 30,20242025202420252024202520242025Forward foreign exchange contracts$(22,556)$(62,013)$(7,666)$(45,461)Revenue$414 $(613)$1,326 $231 Interest rate swaps(1,981)68 917 (2,427)Cost of revenue1,569 (3,052)5,617 (8,771)Treasury rate lock— — (397)— Selling, general and administrative expenses214 (430)1,054 (1,252)Interest expense499 (107)1,244 (331)$(24,537)$(61,945)$(7,146)$(47,888)$2,696 $(4,202)$9,241 $(10,123)

26

GENPACT LIMITED AND ITS SUBSIDIARIESNotes to the Consolidated Financial Statements(Unaudited)(In thousands, except per share data and share count)

6. Derivative financial instruments (Continued)There were no gains (losses) recognized in the statement of income on the ineffective portion of derivatives designated as cash flow hedges and excluded from effectiveness testing for the three and nine months ended September 30, 2024 and 2025, respectively.Non-designated HedgesAmount of Gain (Loss) recognized in Statement of Income on DerivativesThree months ended September 30,Nine months ended September 30,Derivatives not designated as hedging instrumentsLocation of Gain (Loss)  recognized in Statement of Income on Derivatives2024202520242025Forward foreign exchange contracts (Note a)Foreign exchange gains (losses), net$(3,473)$(21,770)$(3,908)$(13,294)$(3,473)$(21,770)$(3,908)$(13,294)(a)These forward foreign exchange contracts were entered into to hedge fluctuations in foreign exchange rates for recognized balance sheet